Inspra: new oral aldosterone antagonist coming soonPfizer plans to launch a new aldosterone antagonist, Inspra (eplerenone 25 mg and 50 mg tablets). Ideas about InfrastructureHealthcare capital planning specialists get together at our second annual Healthcare Infrastructure Summit Retention project gives N.S. nurses another reason to stay in province Program encourages mentoring those entering profession and flexibility for older nurses Google Scholar vs PubMed Google Scholar and PubMed retrieve a similar number of target primary literature articles, according to a recent study. Weight loss supplements for childhood obesity? Most weight loss supplements should not be recommended for children at this time, according to a recent Canadian review. ARTHROPLASTY: Computer-aided knee replacement no better than standard surgery Routine use of time-consuming method appears unwarranted Delivered by delusional defiance Time runs out as a doctor waits for a mentally ill patient's meds to kick in to see if he'll accept cancer care Young MD: The torment of self-exposure It's tough to believe in the legitimacy of both paths when asked, LETTERS: One more teaching tip Providers, MDs clash over sex selection First Previous 3807 3808 3809 3810 3811 Next Last
